Dr. James Campbell has been as the CEO/MD of PAB for almost 7 years. It's not a short period. What's results he gave to shareholders?
Ann: Updated guidance for PAT-DX1 phase 1 clinical study, page-101
-
- There are more pages in this discussion • 25 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PAB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.7¢ |
Change
0.000(0.00%) |
Mkt cap ! $14.40M | |||
| Open | High | Low | Value | Volume |
| 0.7¢ | 0.7¢ | 0.7¢ | $11.67K | 1.667M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 1024077 | 0.7¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.8¢ | 1520772 | 4 |
View Market Depth
| Last trade - 14.28pm 13/09/2024 (20 minute delay) ? |
| PAB (ASX) Chart |